ASHELA BEAN: Open Payments
NPI 1255795027 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 34 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $48 · 2025 $892
Food & beverage: $892
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $259 |
| AstraZeneca Pharmaceuticals LP | 8 | $150 |
| Dexcom, Inc. | 1 | $118 |
| Medtronic, Inc. | 1 | $86 |
| Exact Sciences Corporation | 4 | $70 |
| Lilly USA, LLC | 3 | $65 |
| Abbott Laboratories | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| PFIZER INC. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $25 |
Products named: DEXCOM G7 GSS (161), BREZTRI, VENASEAL, Ozempic, Cologuard Collection Kit, MOUNJARO, FREESTYLE LIBRE 3, Wegovy.
Industry payments across TX — which companies pay providers there.
